Doctors Note Logo

Published on: 10/1/2026

When babies get the MMR vaccine, and why the second dose matters

Babies typically receive their first MMR (measles, mumps, rubella) dose at 12 to 15 months of age, with a second dose given between 4 and 6 years old, though earlier timing may be recommended for international travel or outbreak exposure. The second dose matters because roughly 7 percent of children do not develop full protection from one dose alone, and two doses raise measles effectiveness from about 93 percent to 97 percent while strengthening mumps and rubella immunity. Timing exceptions, catch-up schedules, and expected side effects like mild fever or rash are important factors to consider, so see below for the complete details before making decisions about your child's schedule.

If your baby develops a fever, rash, swelling, or unusual fussiness after vaccination, it can be hard to know what is a normal immune response and what deserves a call to the pediatrician. Take a free, instant, online symptom check to better understand what may be going on and what steps to take next.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

When Do Babies Get the MMR Vaccine (Measles, Mumps, Rubella)?

Vaccinating children against measles, mumps and rubella (MMR) is one of the most effective ways to protect them from serious illness. Understanding when your baby should receive the MMR vaccine – and why both doses are important – helps you make informed decisions for their health.


Recommended MMR Schedule

According to the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics:

  • First dose: 12 to 15 months of age
  • Second dose: 4 to 6 years of age

Key points:

  • The timing balances the loss of maternal antibodies (which can interfere with the vaccine) with the risk of exposure in early childhood.
  • The second dose is given before school entry to ensure full protection as social exposure increases.

In certain situations (e.g., international travel to areas with active measles transmission), the first dose may be given as early as 6 months. However, this early dose does not replace the routine first dose at 12–15 months or the second dose at 4–6 years.


Why the First Dose Is Given at 12–15 Months

Babies carry some immunity from their mother for the first several months of life. Maternal antibodies can reduce the effectiveness of the vaccine if given too early. By 12 months, most of these antibodies have waned, allowing the vaccine to elicit a strong immune response.

Benefits of waiting until 12–15 months:

  • Optimal immune response: The vaccine triggers better antibody production.
  • Reduced interference: Less chance maternal antibodies will neutralize the vaccine virus.
  • Balance of protection and maturity: The child’s immune system is developed enough to respond safely.

Why the Second Dose Matters

Even though about 95% of children develop immunity after the first MMR shot, a small percentage do not respond fully. The second dose covers those “primary vaccine failures” and boosts overall protection.

Benefits of the second dose:

  • Catches non-responders: About 3–5% of children won’t develop immunity after the first shot. The second dose immunizes nearly all of them.
  • Increases community immunity: With two doses, more than 99% of children become immune, helping prevent outbreaks.
  • Long-term protection: Ensures durable immunity through school years and beyond.
  • Herd immunity: Protects infants too young to be vaccinated and people who can’t receive live vaccines due to medical reasons.

Effectiveness and Safety

MMR is a live attenuated vaccine, meaning it contains weakened forms of the viruses. It’s been studied for decades, and safety monitoring has been rigorous.

Common reactions (mild and short-lived):

  • Low-grade fever (up to 5–12 days after vaccination)
  • Mild rash (fades within a few days)
  • Tenderness or swelling at the injection site

Rare but important to know:

  • A febrile seizure can occur in 1 in 3,000 to 4,000 doses, usually linked to fever, not the vaccine itself causing neurologic harm.
  • Very rare allergic reactions (about 1 case per million doses).
  • No credible evidence links MMR to autism or chronic health problems.

Overall, the benefits of vaccination greatly outweigh the risks of these rare events.


What to Expect After Each Dose

After each MMR shot, you may notice:

  • Within 6–12 hours: Mild fussiness or soreness at the injection site.
  • 5–12 days later: Fever or rash in a small number of children.
  • Monitoring: Keep an eye on temperature and general behavior.

If your child develops:

  • High fever (above 104°F or 40°C)
  • Persistent crying for more than 3 hours
  • Signs of serious allergic reaction (hives, swelling of face or throat, difficulty breathing)

…seek medical attention right away and consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Tips for a Smooth Vaccination Experience

  1. Plan ahead

    • Schedule appointments around nap and meal times.
    • Dress your child in clothing that allows easy access to the thigh or upper arm.
  2. Comfort measures

    • Breastfeed or offer a bottle during and after the shot.
    • Use a cool, damp cloth on the injection site if there’s soreness.
  3. Track vaccinations

    • Keep an immunization record or use an app to remind you of upcoming doses.
    • Some schools and day cares require proof of two MMR doses.
  4. Stay informed

    • Ask your pediatrician to walk you through each step.
    • Review credible resources such as CDC.gov or AAP guidelines.

Addressing Common Concerns

Q: My child had a mild reaction after the first dose. Should I skip the second?
A: No. Mild reactions are normal and not a reason to skip the second shot. A second dose is safe and necessary to ensure full immunity.

Q: Can my child get MMR at the same visit as other vaccines?
A: Yes. MMR can safely be given alongside other routine childhood vaccines, such as DTaP, IPV and Hib.

Q: What if we’re traveling internationally?
A: If traveling to a measles-endemic area before 12 months, the first dose can be given at 6–11 months. You’ll still need the routine two-dose series.


Final Thoughts

The MMR vaccine is a cornerstone of pediatric care. By following the recommended schedule—first dose at 12–15 months and second at 4–6 years—you ensure your child and your community stay protected against measles, mumps and rubella.

Remember:

Speak to a doctor if you have any questions or concerns about vaccination, especially if your child has had serious reactions in the past. It’s the best way to keep your child healthy today—and for years to come.

(References)

  • * Edwards KM. Pediatric immunizations. Curr Probl Pediatr. 1993 May-Jun;23(5):186-209. doi: 10.1016/0045-9380(93)90015-5. PMID: 8354078.

  • * Paterson R. MMR debate fall-out continues. Lancet Infect Dis. 2004 Nov;4(11):653. doi: 10.1016/s1473-3099(04)01187-9. PMID: 15534938.

  • * Weir E. Measles, again--and its implications for occupational health. CMAJ. 2006 Apr 25;174(9):1259. doi: 10.1503/cmaj.051508. PMID: 16636323; PMCID: PMC1435963.

  • * Mathew A. Global access to vaccines: Vaccine sale is not tailored to improving India's health. BMJ. 2008 May 3;336(7651):975. doi: 10.1136/bmj.39563.536157.BE. PMID: 18456606; PMCID: PMC2364820.

  • * Aronsson B, Blennow M. [A special immunization clinic tailors vaccinations]. Lakartidningen. 2008 May 28-Jun 3;105(22):1675-9. PMID: 18590010.

  • * Gaudelus J. [Vaccine coverage in children]. Arch Pediatr. 2010 Jun;17(6):955-7. doi: 10.1016/S0929-693X(10)70196-2. PMID: 20654978.

  • * Romain O. [Immunization of newborn and his entourage]. Arch Pediatr. 2010 Jun;17(6):958-9. doi: 10.1016/S0929-693X(10)70197-4. PMID: 20654979.

  • * De Laval F, Haus R, Spiegel A, Simon F. Lower long-term immunogenicity of mumps component after MMR vaccine. Pediatr Infect Dis J. 2010 Nov;29(11):1062-3; author reply 1063. doi: 10.1097/INF.0b013e3181f2d864. PMID: 20975455.

  • * Helwig H, Cremer H. [Measles. Elimination almost achieved!]. Kinderkrankenschwester. 2012 Jun;31(6):234-7. PMID: 22808669.

  • * McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. PMID: 23760231.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.